tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Positive Outlook for Eledon Pharmaceuticals Driven by Promising Tegoprubart Phase 1b Study Results
PremiumRatingsPositive Outlook for Eledon Pharmaceuticals Driven by Promising Tegoprubart Phase 1b Study Results
1M ago
Promising Phase 1b Results of Tegoprubart Support Buy Rating for Eledon Pharmaceuticals
Premium
Ratings
Promising Phase 1b Results of Tegoprubart Support Buy Rating for Eledon Pharmaceuticals
1M ago
Eledon Pharmaceuticals announces updated data from tegoprubart trial
Premium
The Fly
Eledon Pharmaceuticals announces updated data from tegoprubart trial
1M ago
Eledon Pharmaceuticals: Promising Advances in Organ Transplant Rejection Prevention with Tegoprubart
PremiumRatingsEledon Pharmaceuticals: Promising Advances in Organ Transplant Rejection Prevention with Tegoprubart
2M ago
Eledon Pharmaceuticals’ Tegoprubart: Promising Clinical Potential in Kidney Transplantation and Strategic Targeting Advantages
Premium
Ratings
Eledon Pharmaceuticals’ Tegoprubart: Promising Clinical Potential in Kidney Transplantation and Strategic Targeting Advantages
2M ago
Sernova enters collaborative research agreement with Eledon Pharmaceuticals
Premium
The Fly
Sernova enters collaborative research agreement with Eledon Pharmaceuticals
2M ago
Eledon Pharmaceuticals: Strong Financials and Promising Trials Justify Buy Rating
PremiumRatingsEledon Pharmaceuticals: Strong Financials and Promising Trials Justify Buy Rating
4M ago
Eledon Pharmaceuticals reports Q1 EPS (8c), consensus (30c)
Premium
The Fly
Eledon Pharmaceuticals reports Q1 EPS (8c), consensus (30c)
4M ago
Eledon Pharmaceuticals Reports 2024 Financial Results and Clinical Advances
Premium
Company Announcements
Eledon Pharmaceuticals Reports 2024 Financial Results and Clinical Advances
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100